Michael Holfinger

Before joining Alladapt, Dr. Holfinger was Vice President of Chemistry Manufacturing and Controls at Pliant Pharmaceuticals where he was responsible for all process/product development, manufacturing/supply, and analytical development/quality control activities to support clinical development of multiple small molecule drug candidates. Prior to this, he spent five years as SVP Technical Operations at Aimmune Therapeutics where as he was responsible for all process/product development, manufacturing, supply chain, and analytical development/quality control activities to support clinical development and commercialization of PalforziaTM, an FDA-approved biologic oral immunotherapy product for the treatment of pediatric peanut allergy. Dr. Holfinger's earlier career included increasingly responsible positions at Alexza, Affymax, Pfizer, Pharmacia and Upjohn. He earned a PhD in Chemical Engineering from the University of Wisconsin-Madison, and dual Bachelor of Science degrees in Applied Science and Chemistry from Miami University.